Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tirzepatide: The Double-Barrel GLP-1 and GIP Agonist Tirzepatide (sold under brand names like Mounjaro and Zepbound ) is a dual-action peptide that activates both GLP-1 and GIP receptors
By crossing the blood-brain barrier, DSIP acts at the core of neural and systemic balance, enabling a multidimensional therapeutic impact ( 8, 9 )
This is not a complete summary of risks
It is also important to set realistic expectations regarding the timeline for clinical benefits
At Optimal Health Medical, conversations about peptide therapy are approached through medical evaluation, symptom review, medication and supplement review, lab-informed decision-making when appropriate, realistic expectations, safety education, and follow-up
Archives of disease in childhood, 77(2), 137-139
